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Peripheral neuropathy is a widespread and potentially incapacitating pathological condition
that encompasses more than 100 different forms and manifestations of nerve damage.
The diverse pathogenesis of peripheral neuropathy affects autonomic, motor and/or
sensory neurons, and the symptoms that typify the condition are abnormal cutaneous
sensation, muscle dysfunction and, most notably, chronic pain. Chronic neuropathic pain
is difficult to treat and is often characterized by either exaggerated responses to painful
stimuli (hyperalgesia) or pain resulting from stimuli that would not normally provoke pain
(allodynia). The objective of this review is to provide an overview of some pathways
associated with the development of peripheral neuropathy and then discuss the benefits
of exercise interventions. The development of neuropathic pain is a highly complex and
multifactorial process, but recent evidence indicates that the activation of spinal glial
cells via the enzyme glycogen synthase kinase 3 and increases in the production of both
pro-inflammatory cytokines and brain derived neurotropic factor are crucial steps. Since
many of the most common causes of peripheral neuropathy cannot be fully treated, it
is critical to understand that routine exercise may not only help prevent some of those
causes, but that it has also proven to be an effective means of alleviating some of the
condition’s most distressing symptoms. More research is required to elucidate the typical
mechanisms of injury associated with peripheral neuropathy and the exercise-induced
benefits to those mechanisms.
Keywords: peripheral neuropathy, neuropathic pain, exercise, inflammation, microglia, glycogen synthase kinase,
cytokines
INTRODUCTION
The etiology and pathology of peripheral neuropathy are complex
and diverse. Additionally, the 108th U.S. Congress estimated that
peripheral neuropathy affects at least 20 million U.S. Citizens,
which is roughly 18% more Americans than are currently thought
to be afflicted by coronary artery disease (Lloyd-Jones et al., 2009)
and roughly 54% more than are currently thought to have some
form of cancer (Howlader et al., 2012).
The defining characteristic of peripheral neuropathy is damage
to the axons and/or myelin of one or more peripheral nerves,
which often results in abnormal nerve conduction (e.g., low
amplitudes or slow velocity) and/or spontaneous activity (Azhary
et al., 2010). It is also typical for the deterioration to begin
distally and then move progressively in a proximal or ascending
manner. Yet, there are over 100 types of peripheral neuropathy
(National Institute of Neurological Disorders and Stroke, 2012)
and each differs not just in terms of etiology and the pattern of
development, but also in terms of the nerves that are affected
and the resulting symptoms. For example, damage occurring to
autonomic nerves could lead to symptoms such as impaired:
ventilation, blood pressure regulation, bladder control, digestion,
sweating and tolerance to the heat However, it is more common
for the condition to affect motor and sensory nerves, resulting in
symptoms such as: muscle spasticity, muscle atrophy and strength
loss; loss of sensations including vibration, touch, temperature
and proprioception; and the presence of sensations such as tin-
gling, burning and pain (Azhary et al., 2010; National Institute of
Neurological Disorders and Stroke, 2012).
The complex symptomology of peripheral neuropathy is also
attributed to the diverse etiology of the condition, which includes
dozens of causes that are acquired, as well as some that are
hereditary such as Refsum and Charcot-Marie-Tooth diseases
(National Institute of Neurological Disorders and Stroke, 2012).
The means by which neuropathy may be acquired include: phys-
ical injury (trauma); excessive exposure to toxins such as alcohol
or heavy metals; deficiencies in vitamins including E, B6 and B12;
or diseases such as Lyme and human immunodeficiency virus
(Azhary et al., 2010). That said, it is estimated that as much as
30% of the cases of peripheral neuropathy are idiopathic (Smith
and Singleton, 2006), whereas the majority of cases of the disease
occur in conjunction with diabetes mellitus (National Institute of
Neurological Disorders and Stroke, 2012).
The primary purpose of this review is to discuss the potential
benefits of exercise as an intervention for those with peripheral
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FIGURE 1 | Overview of potential benefits of exercise intervention on neuropathic pain.
neuropathy. Figure 1 illustrates the flow of the discussions within
this review. Because the mechanisms that underlie those benefits
are not fully understood, we hope this review will help encour-
age further investigation to elucidate those mechanisms. To that
end, we will also highlight a number of potentially important
mechanisms by first summarizing key evidence concerning the
development of both diabetic neuropathy and neuropathic pain.
Although there are many other causes of peripheral neuropathy
and the symptoms of the condition do not always include pain,
the bulk of pertinent research has focused on these concerns and
it is likely other manifestations of the condition share similar
mechanisms of injury.
DIABETIC NEUROPATHY
According to the Centers for Disease Control (Centers for Disease
Control and Prevention, 2011), roughly 26 million American
adults and children currently have diabetes mellitus, and 60–
80% of those afflicted with the disease are expected to develop
neuropathy. Among the collection of syndromes associated with
peripheral neuropathy, the most common in diabetics is distal
symmetrical sensorimotor polyneuropathy, which is often simply
called diabetic neuropathy (Jack and Wright, 2012). A hallmark
of diabetic neuropathy is symmetrical degeneration of small
cutaneous sensory fibers, including myelinated A-δ and unmyeli-
nated C-fibers, which are responsible for conveying cutaneous
sensations like pain (Talbot and Couture, 2012). Accordingly,
techniques that assess small fiber abnormalities, such as quanti-
tative sensory testing (QST), intraepidermal nerve fiber (IENF)
density and corneal confocal microscopy (CCM), can be effective
means of detecting early diabetic neuropathy (Tavakoli et al.,
2010). It is also not surprising that diabetes is the leading cause
of painful neuropathy (Talbot and Couture, 2012) and that 30%
of diabetics over the age of 40 have impaired sensation in their
hands and/or feet (Centers for Disease Control and Prevention,
2011).
A crucial feature in the pathogenesis of diabetic neuropathy is
hyperglycemia, and poor blood glucose control is recognized as a
leading risk factor in the development of neurological problems
(Jack and Wright, 2012; Talbot and Couture, 2012). One essential
consequence of hyperglycemia is that it accelerates the production
of advanced glycation end products (AGEs) in the tissues where
damage occurs, including the peripheral nerves. AGEs are formed
from at least two distinct pathways; one is the classic or glycation
pathway and the other is the oxidative pathway. In the glycation
pathway, a monosaccharide (e.g., glucose, fructose or galactose)
and an amino group reversibly form an Amadori product (e.g.,
hemoglobin A1c), which may then be used to irreversibly generate
an AGE (Huebschmann et al., 2006). The second pathway occurs
in the presence of oxidative stress or reactive oxygen species
(ROS), which become reactive dicarbonyl components that react
with proteins, lipids and DNA to form AGEs (Jack and Wright,
2012). Hyperglycemia accelerates the production of AGEs from
both the glycation and oxidative pathways (Huebschmann et al.,
2006); consequently, it provides a key to understand why diabetics
have extensive accumulations of AGEs in cells like myelinated and
unmyelinated neurons, Schwann cells and microvessels (Jack and
Wright, 2012).
Accumulated AGEs, along with other mechanisms that are
enhanced with diabetes, such as oxidative stress, are likely sig-
nificant contributors to the development of diabetic neuropathy
(Andreassen et al., 2009; Nguyen et al., 2012). AGEs promote
vascular disease (e.g., endothelial dysfunction, atherosclerosis and
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chronic vasoconstriction), which impairs neuron function by
reducing blood flow (Huebschmann et al., 2006). AGEs also
directly impair neuron function by modifying proteins in a
manner that impairs vital cellular processes (e.g., regenerative
capacity) and by initiating intracellular signaling cascades that
increase the production of ROS and the expression of pro-
inflammatory cytokines (Jack and Wright, 2012). For example,
when AGEs interact with cell receptors for advanced glycation
end products (RAGE), numerous intracellular signaling pathways
are triggered that, in turn, may activate the DNA transcription
factor NF-KB (e.g., nuclear factor kappa-light-chain-enhancer of
activated B cells). NF-KB activation increases both the expression
of pro-inflammatory cytokines interleukin 6 (IL-6) and tumor
necrosis factor α (TNFα) and the expression of RAGE (Jack
and Wright, 2012). The resulting enhanced AGE-RAGE interac-
tion, NF-KB activation, and ROS production contribute to the
development of persistent inflammation that damages peripheral
neurons (Nguyen et al., 2012), causes pain (Bierhaus et al., 2004)
and, more importantly, activates microglia (Talbot and Couture,
2012).
NEUROPATHIC PAIN AND ACTIVATED GLIA
Acute pain is informative and serves as a warning against impend-
ing or current tissue damage, whereas chronic pain is itself a
pathological condition that serves no beneficial function. Chronic
neuropathic pain is characterized by exaggerated responses to
painful stimuli (hyperalgesia), pain resulting from stimuli that
would not normally provoke pain (allodynia) and by abnormal
pins and needles sensations. The transition from acute pain to
chronic neuropathic pain is a highly complicated process that
results in dysfunction throughout the pain transmission pathway,
from the nociceptors (Ren and Dubner, 2010) to the dorsal root
ganglion and spinal cord (Trang et al., 2011) to the thalamus
(Fischer and Waxman, 2010) and, finally, the cerebral cortex
(Zhuo et al., 2011). However, evidence strongly indicates that
the activation of microglia in the dorsal horn of the spinal cord
is a critical component in the initiation and maintenance of
neuropathic pain (Scholz and Woolf, 2007; Leung and Cahill,
2010; Wen et al., 2011).
Microglial cells account for 5–12% of the total cells in the
central nervous system and they typically exist in a relatively
quiescent form, in which they contain long branching processes
that monitor the physiological conditions of the surrounding
environment (Perry et al., 2007). When microglia detect damage
to surrounding neurons (e.g., peripheral nerve injury), they pro-
liferate to form dense clusters, take on an amoeboid form and
they begin to phagocytize cellular debris and foreign material.
Under these conditions, the microglia are triggered by a num-
ber of complex signaling cascades, the details of which extend
beyond the scope of this review (see Ren and Dubner, 2010;
Scholz and Woolf, 2007 for reviews). However, the activation
via adenosine triphosphate (ATP) interacting with P2 puriner-
gic receptors has been identified as a particularly critical event.
For example, a pivotal study by Tsuda et al. (2003) demon-
strated the activation of P2X4 receptors in spinal microglia is
necessary for tactile allodynia following nerve injury. Microglial
activation via both ATP and tumor necrosis factor (TNF) leads
to the phosphorylation (activation) of mitogen-activated pro-
tein kinases (MAPKs), including: extracellular signal-regulated
kinases (ERK); Jun N-terminal kinases (JNKs); and, most notably,
p38-MAPK. Chronic upregulation of P2X receptors and activa-
tion of MAPK signaling are considered essential components in
the development and maintenance of neuropathic pain (Scholz
and Woolf, 2007; Leung and Cahill, 2010; Trang et al., 2011;
Wen et al., 2011) because they cause the following three sig-
nificant actions. First, activated microglia synthesize and release
brain-derived neurotrophic factor (BDNF), which encourages
the growth and differentiation of neurons and synapses. Under
pathological conditions, the BDNF released from microglia
increases the excitability of nociceptive neurons (Ren and Dubner,
2010), reduces inhibitory γ-aminobutyric acid neurotransmission
(Coull et al., 2005) and causes abnormal nociceptive processing
that leads to hyperalgesia and allodynia (Kerr et al., 1999). Sec-
ond, activated microglia release the pro-inflammatory cytokines
TNFα., interleukin 1β (IL-1β) and IL-6. These inflammatory
cytokines promote numerous pertinent actions associated with
neuropathy and neuropathic pain, including: amplification of
microglial activation (Zhuo et al., 2011); infiltration of phagocytic
neutrophils (Nadeau et al., 2011); damage to Schwann cells (Xu
and Yaksh, 2011); damage to axons and increases in nociceptor
sensitivity (Schafers et al., 2003; Cunha et al., 2005); increased
conductance in dorsal root ganglion neurons (Czeschik et al.,
2008); and hyperactivity in dorsal horn neurons (Kawasaki et al.,
2008; Ren and Torres, 2009). Third, activated microglia, along
with the accumulation of pro-inflammatory cytokines and stim-
ulation via purinergic receptors, cause spinal astrocytes to prolif-
erate and became active (Maixner and Weng, 2013). Much like
activated microglia, activated astrocytes promote (dorsal horn)
neuron dysfunction by releasing BDNF (Ren and Dubner, 2010),
IL-1β, IL-6 and TNFα (Beurel et al., 2010). However, because
their activation is more prolonged than that of microglia, astro-
cytes are required to perpetuate the neuronal hyperexcitability,
neurotoxicity and inflammation that characterizes neuropathic
pain (Ji and Suter, 2007; Gosselin et al., 2010; Zhuo et al.,
2011).
GLIAL GLYCOGEN SYNTHASE KINASE 3 REGULATES
NEUROINFLAMMATION
Glycogen synthase kinase 3 (GSK-3) mediates the addition of
phosphate molecules onto more than 40 proteins in a variety
of different pathways (typically inhibiting them), but it perhaps
best known for its role in the regulation of glycogen synthe-
sis. GSK-3 is a highly conserved protein kinase and its α- and
β-isoforms are expressed in practically all mammalian tissues
(Kaidanovich-Beilin and Woodgett, 2011). GSK-3 is a point of
convergence of many different signaling pathways, it is known
to regulate more than 20 transcription factors and it acts as a
critical trigger both in the activation of glial cells and with the
balance between pro-inflammatory and anti-inflammatory states
(Beurel et al., 2010). In active microglia and astrocytes, GSK-
3 promotes the release of IL-1β, IL-6 and TNFα and inhibits
the release of anti-inflammatory cytokines like IL-10 (Beurel
et al., 2010; Kaidanovich-Beilin and Woodgett, 2011; Maixner and
Weng, 2013).
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Although it is typically active in cells under resting conditions,
GSK-3 is one of the few protein kinases that can be inhibited
by extracellular factors via rapid phosphorylation of its serine
residues. The extracellular signals that are known to inhibit GSK-3
include epidermal and platelet-derived growth factors (Stambolic
et al., 1996; Shaw and Cohen, 1999), α1A, adrenergic receptor
stimulation (Bailou et al., 2001) and insulin (Markuns et al.,
1999). Given the typical fluctuations in insulin levels, and because
the hormone is particularly relevant to this review (i.e., diabetic
neuropathy is the leading cause of neuropathy), it is worth
noting both that insulin uses the Akt/protein kinase B pathway
to phosphorylate GSK-3 (Cross et al., 1995) and that insulin’s
effect on GSK-3 is altered by angiotensin II (Diamond-Stanic
and Henriksen, 2010) and α1A (Bailou et al., 2001) stimulation.
That said, it is clear that significant/prolonged inactivation of
GSK-3 in microglia and astrocytes shifts balance of secreted
cytokines from pro-inflammatory to anti-inflammatory (Beurel
et al., 2010). For example, pharmacological inhibition of GSK-3
activity in activated glial cells has been shown to reduce elevated
secretions of TNFα and IL-1β (Wang et al., 2010; Green and
Nolan, 2012), to elevate decreased secretions of IL-10 (Green and
Nolan, 2012) and to reduce neuropathic pain (Mazzardo-Martins
et al., 2012).
EXERCISE AND PERIPHERAL NEUROPATHY
Most cases of peripheral neuropathy cannot be fully treated
because the underlying cause is either unknown (i.e., idiopathic
neuropathy) or it cannot be cured (e.g., inherited and diabetic
neuropathies). Therefore, the major goal associated with the
treatment of most forms of peripheral neuropathy is to control
or ameliorate the troublesome symptoms (National Institute of
Neurological Disorders and Stroke, 2012). To summarize the
above sections, the symptoms that typify peripheral neuropathy
are numbness, reduced proprioception, weakness, poor balance
and, in particular, allodynia and hyperalgesia,; the mechanisms
that underlie those symptoms may include: hyperglycemia and
AGEs (diabetic neuropathy), GSK-3 and glial activation, and
elevated levels of the pro-inflammatory cytokines TNFα, IL-1β
and IL-6.
As we (Li and Hondzinski, 2012) have observed before, rou-
tine exercise can be a beneficial addition to medical and phar-
maceutical treatments for people with peripheral neuropathy.
According to the U.S. Surgeon General (U.S. Department of
Health and Human Services, 1996) and the American College of
Sports Medicine (American College Sport Medicine, 2010), the
myriad relevant preventative benefits of routine exercise include:
enhanced macro- and micro-vascular health (e.g., better endothe-
lial function, reduced vasoconstriction and enhanced blood flow);
reduced risk of hypertension, atherosclerosis and numerous car-
diovascular diseases; decreased production of ROS and increased
anti-oxidant defenses; reduced risks of certain types of cancer;
increased muscle strength and cardiorespiratory endurance. With
specific regard to the most common cause of peripheral neuropa-
thy (i.e., diabetes), exercise is also well-known to reduce: blood
glucose levels, the formation of Amadori products (Balducci
et al., 2010; Ahn and Song, 2012; Kluding et al., 2012), the
accumulation of AGEs (Boor et al., 2009; Yoshikawa et al., 2009;
Kotani et al., 2011) and the risk of developing type II diabetes and
metabolic syndrome (American College Sport Medicine, 2010; Li
and Hondzinski, 2012).
In contrast to the many benefits listed above, the relationships
between exercise and both glia activation and GSK-3 activity
have not been extensively studied and remain less clear. For
example, although a number of studies (Markuns et al., 1999;
Sakamoto et al., 2003; Aschenbach et al., 2006) have demonstrated
that a single bout of exercise can temporarily phosphorylate
(inactivate) GSK-3 in rodents, the evidence in humans has been
more inconsistent (Nielsen and Richter, 2003; Sakamoto et al.,
2004). Furthermore, a recent study by Manabe and co-workers
(Manabe et al., 2013) found that chronic exercise training actually
resulted in prolonged increases in GSK-3β activity in rodents.
However, it is very important to point out that, in all of the
studies just mentioned, GSK-3 activity was measured in enzymes
that were within the skeletal muscles that had been involved in
the exercise. To the best of the authors’ knowledge, only one
study (Bayod et al., 2011) has investigated the effect of exercise
on GSK-3 activity in cells located within the central nervous
system (i.e., where glia are located), and that study found that
training resulted in prolonged reductions in GSK-3 activity in
rodent hippocampal cells. It is also important to note that the
effects of exercise on skeletal muscle GSK-3 activity are thought to
be triggered specifically by tension within the muscle (Sakamoto
et al., 2003). Therefore, whatever effects exercise has on spinal
glia would have to be initiated in a different manner and, conse-
quently, would likely involve different signaling pathways. While
there is some evidence that exercise training alters the activity
of astrocytes (Bernardi et al., 2013) and microglia (Cobianchi
et al., 2010), the relationship between exercise, glial activation
and neuropathic pain requires much more investigation. That
said, future studies in this area should take into consideration
the following two sets of relevant evidence. First, norepinephrine,
which is increased systemically during exercise via enhanced sym-
pathoadrenal activity, may inactivate GSK-3β (Bailou et al., 2001)
and has been shown to reduce both the proliferation of microglia
and the release of pro-inflammatory cytokines from microglia and
astrocytes (O’Donnell et al., 2012). Second, contracting muscles
secrete cytokines (i.e., myokines) that tend to have more anti-
inflammatory properties (Moldoveanu et al., 2001; Brandt and
Pedersen, 2010; National Institute of Neurological Disorders and
Stroke, 2012), and routine exercise helps prevent and/or reduce
low-grade systemic inflammation (Smith et al., 1999; Mathur and
Pedersen, 2009; Phillips et al., 2010; Gano et al., 2011; Hopps et al.,
2011; Irwin and Olmstead, 2012).
Aside the preventative and more general benefits of exercise
just summarized, it is clear that routine exercise may be a highly
effective means of enhancing the recovery from, and/or reducing
some of the distressing symptoms associated with, peripheral
neuropathy. Among the dozens of pertinent studies, a substantial
number focused on the effect of either strength-stability exercises
(e.g., Tai Chi) or aerobic exercise (e.g., walking) in humans
with diabetic peripheral neuropathy. All of the remaining studies
examined the effect of aerobic exercise (e.g., treadmill running) in
rodents either with diabetic peripheral neuropathy or following
nerve trauma that was elicited via acid, crushing or cutting.
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Because the mechanisms investigated and benefits identified with
both of those subgroups of neuropathic rodents were the same,
the results of both sets of rodent studies will be generalized in the
following discussion.
Beginning with the components that are most directly affected
by peripheral neuropathy, routine exercise has been shown to both
preserve and promote the function of the peripheral nerves. For
example, Balducci et al. (2006) compared people with diabetes
following 4 years of aerobic exercise training vs. control and found
that significantly fewer of those in the exercise group developed
motor (0% vs. 17%, respectively) and sensory (6% vs. 30%)
nerve dysfunction. Among those who have already suffered nerve
damage, the evidence from rodent studies indicates that aerobic
exercise promotes peripheral nerve regeneration following injury
(Ilha et al., 2008; Malysz et al., 2010; O’Donnell et al., 2012).
Additionally, routine exercise has been shown to both enhance
peripheral nerve conduction velocity (Balducci et al., 2006; Hung
et al., 2009) and increase IENF branching (Kluding et al., 2012)
and density (Smith et al., 2006) in diabetic humans. On a related
note, it is possible that exercise training could elicit favorable
adaptions in the nervous system via plasticity mechanisms and
by retraining neural pathways, but, to the best of the authors’ our
knowledge, this has not been investigated.
The most frequently cited relevant benefit of exercise has been
its positive effects on sensation, and most notably neuropathic
pain. In rodents, aerobic exercise training has been shown to
delay the onset of diabetic pain (Chen et al., 2013) and tactile
hypersensitivity (Shankarappa et al., 2011), and to also reduce
mechanical allodynia (Sharma et al., 2010; Bobinski et al., 2011;
Stagg et al., 2011; O’Donnell et al., 2012; Cobianchi et al., 2013)
and hyperalgesia (Hutchinson et al., 2004; Chen et al., 2013; Sluka
et al., 2013) following injury. Similarly, routine exercise not only
alleviates neuropathic pain in humans, but it has also been shown
to increase cutaneous (i.e., plantar) sensation (Li and Manor,
2010) and the ability to perceive vibrations (Balducci et al., 2006).
Those sensory benefits, along with improvements in trunk (Song
et al., 2011) and ankle proprioception (Xu et al., 2004), likely
contribute to the positive effect that exercise training, and in
particular Tai Chi, has on balance (Orr et al., 2006; Morrison et al.,
2010; Song et al., 2011; Ahn and Song, 2012; Akbari et al., 2012; Li
and Hondzinski, 2012) and functional mobility (Orr et al., 2006;
Li and Manor, 2010; Song et al., 2011) in those with peripheral
neuropathy.
As to the physiological explanations for the benefits just
described, few studies have investigated the effects of exercise
on the typical mechanisms of injury with peripheral neuropathy
that were discussed above. For example, routine exercise has
been shown to decrease levels of pro-inflammatory cytokines in
diabetic humans (Dekker et al., 2007; Balducci et al., 2010) and
rats (Teixeira de Lemos et al., 2009), but exactly how exercise-
induced changes in cytokines affect those with peripheral neu-
ropathy has yet to be fully explored. As to BDNF, studies have
demonstrated that exercise training tends to elevate the expression
of BDNF in both the CNS (Gomez-Pinilla et al., 2012; Rothman
et al., 2012) and skeletal muscles (Gomez-Pinilla et al., 2012)
and that those increases may be beneficial to cognition and
the health of the brain (Rothman et al., 2012). However, as
discussed above, excessive levels of BDNF in sensory locations
like the dorsal horn and dorsal root ganglion are associated with
abnormal nociceptive processing and the development of neuro-
pathic pain. That said, BDNF does play an important role in the
regeneration of injured peripheral axons (Wilhelm et al., 2012),
and there is some evidence exercise increases BDNF expression
in motor, but not sensory, neurons following peripheral nerve
injury (Keeler et al., 2012). Furthermore, Cobianchi et al. (2013)
demonstrated that aerobic exercise training reduced both levels of
BDNF in the dorsal root ganglion and neuropathic pain in rats
following peripheral nerve injury. Similarly, Detloff et al. (2014)
very recently showed that aerobic exercise can normalize spinal
levels of glial cell-derived neurotrophic factor (GDNF), prevent
excessive sprouting of pain afferents and reduce tactile allodynia
in rats following spinal cord injury.
To summarize, the relationships between exercise and
cytokines, BDNF, glia and GSK-3 in those with peripheral neu-
ropathy have yet to be elucidated and must continue to be studied.
Additionally, a number of additional important mechanisms have
recently been identified and, although it is not clear how they
interact with those discussed above, these novel mechanisms have
been linked to pertinent exercise-induced benefits and should
therefore continue to be explored.
The first such novel mechanism is neurotrophin-3 (NT-3),
which is known to promote the survival and differentiation of
existing neurons and to encourage the growth of new synapses
and neurons. Aerobic exercise training has been shown to increase
the expression NT-3 in rodents in the spinal cord (Gómez-Pinilla
et al., 2001) and skeletal muscles of both diabetics (Li et al., 2012)
and those recovering from peripheral nerve injury (Hutchinson
et al., 2004). Those observed exercise-induced elevations of NT-
3 were associated with increases in peripheral nerve conduction
velocity (Li et al., 2012) and reductions in neuropathic pain
(Sharma et al., 2010).
A second mechanism that has recently been shown to provide
pertinent benefits is endogenous opiates such as met-enkephalin
and β-endorphin. The production of these opiates is enhanced
during exercise, and their action promotes analgesia and feelings
of well-being (e.g., “runners high”). It is therefore not surprising
that exercise–induced increases in endogenous opiates accompany
reductions in neuropathic pain in rats with diabetes (Shankarappa
et al., 2011) and following nerve injury (Bement and Sluka, 2005;
Sluka et al., 2013). Furthermore, Stagg et al. (2011) demonstrated
not only that aerobic exercise training reduced neuropathic pain,
but that the analgesic effect depended on the stimulation of
central opioid receptors.
The third and final mechanism that is affected by exercise and
helps to counteract the dysfunction associated with peripheral
neuropathy is heat shock protein 72 (HSP72). HSP72 is a member
of a family of heat shock proteins (i.e., the 70 kilodalton family)
that is known to fold proteins, including refolding denatured
proteins, and is needed to help protect cells from stress (Yamada
et al., 2008). The expression of HSP72 tends to decrease with
diseases like diabetes (Atalay et al., 2004) but aerobic exercise
enhances its expression throughout the body, including in the
peripheral nerves and spinal cord (Chen et al., 2013) and in
skeletal muscles (Ogata et al., 2009). HSP72 has been shown to
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increase tolerance to inflammatory cytokines, and there is some
evidence that it may reduce their secretion by inactivating the
NF-KB pathway (Yamada et al., 2008). Additionally, a very recent
study by Chen et al. (2013) demonstrated that exercise-induced
increases in HSP72 delayed the onset hyperalgesia and mechanical
allodynia in diabetic rats.
There are many studies that focus exercise induced changes
due to neuroplasticity. That is beyond the scope of this review.
Please note this limitation of current review and seeking in depth
information in regarding exercise and neuroplasticity among peo-
ple with neuropathic pain elsewhere.
CONCLUSIONS
There are a great many different causes of, and symptoms
associated with, peripheral neuropathy. However, many of the
most common manifestations of the condition involve chronic
neuroinflammation and neuropathic pain, and current evidence
indicates the mechanisms underlying those manifestations may
include: hyperglycemia and AGEs (diabetic neuropathy), GSK-
3 and glial activation and elevated levels of both BDNF and
the pro-inflammatory cytokines TNFα, IL-1β and IL-6. Although
there is no cure for most forms of peripheral neuropathy, routine
exercise may either prevent or delay the onset of the some of
the most common causes. As to the studies that investigated the
treatment benefits of exercise training, nearly all focused on dia-
betic neuropathy or on animals following spinal cord/nerve injury
induction, and so their findings cannot generalize to all forms
of peripheral neuropathy. Nevertheless, the models used in those
investigations included the most common cause of peripheral
neuropathy (i.e., diabetes); they studied the characteristics that
are central to all forms of the condition (e.g., nerve damage and
dysfunction); and the benefits they reported are relevant to the
symptoms of nearly all manifestations of the condition. Those
benefits of exercise training include improvements in nerve func-
tion, reductions in neuropathic pain, reductions in other types of
sensory dysfunction (e.g., numbness) and improvements in both
static and dynamic functional mobility in those with peripheral
neuropathy. Therefore it may be conclude that exercise training
can be an effective intervention for many of those symptoms
associated with peripheral neuropathy.
Future research in this area should continue to investigate
the relationship between both glial GSK-3 activity and levels of
TNFα, IL-1β and IL-6 and exercise-induced reductions in neuron
dysfunction, neuropathic pain and neuroinflammation. Future
studies should also continue to investigate if the specific nature
of the exercise- induced benefits varies with the mode of training
(aerobic vs. strength). The authors hypothesize that a combined
aerobic and strengthening activity such as Tai Chi will promote
a relatively broad range of benefits to those with peripheral
neuropathy.
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